Stock UniverseDerived research view · source repositories remain read-only

Zoetis Inc. (ZTS)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Qualified
Selection Score
37.93
Global Rank
715
Market Cap
55.34B
Latest Close
79.44
RS Composite
-34.44% · G#3122

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-28.57%
3M
-34.30%
6M
-34.63%
1Y
-52.15%
3Y
-49.47%
5Y
-52.71%
10Y
81.99%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 5.29M · 30-day average: 8.25M · Max drawdown over stored range: -68.48%

Research Snapshot

Relative Strength vs SPX

RS Composite-34.44%
20D RS-9.65%
60D RS-42.37%
120D RS-38.90%
Global RS Rank3122 · 6.94% percentile
Qualified+ RS Rank1199 · 4.69% percentile
Group ScopeQualified+
Primary RS Rank386 · 15.72% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank104 / 701
Primary Percentile85.31
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-079.51B4.17Bn/a2.64B6.044.38B1.06B3.32B437M43.82%n/a27.79%46.04%34.91%1.94B9.04B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$6.0413.1x$21.743.7x$7.5910.5x$10.017.9x

Shares Diluted: 437M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue77768080854492569467
Revenue Growth (YoY)16.494%3.909%5.743%8.333%2.28%
Gross Profit54815634598465386806
Operating Income28112936307033993625
Free Cash Flow17361326162122982283
Free Cash Flow Per Share3.6422.8193.5075.0525.144
EPS (Diluted) GAAP4.274.495.075.476.02
EPS Growth24.854%5.152%12.918%7.89%10.055%
EPS Non-GAAP
Gross Margin70.486%69.728%70.037%70.635%71.892%
Operating Margin36.15%36.337%35.932%36.722%38.291%
Profit Margin26.196%26.163%27.434%26.858%28.235%
Free Cash Flow Margin22.325%16.411%18.972%24.827%24.115%
Shares Outstanding (Diluted)476.717470.385462.269454.848443.835
Shares Change (YoY)-0.387%-1.328%-1.725%-1.605%-2.421%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-072.26B39.61%n/an/a601.00M26.57%1.42422.40M1.94B9.04Bprocessed
2025 Q42026-02-122.39B42.86%n/an/a603.00M25.26%1.38438.54M2.31B9.04Bprocessed
2025 Q32025-11-042.40B45.83%n/an/a721.00M30.04%1.63443.20M2.08B7.07Bprocessed
2025 Q22025-08-052.46B46.67%n/an/a718.00M29.19%1.61445.50M1.44B5.23Bprocessed
2025 Q12025-05-062.22B44.32%n/an/a631.00M28.42%1.41448.00M1.72B5.23Bprocessed
2024 Q42025-02-132.32B44.37%n/an/a581.00M25.08%1.29451.09M1.99B5.22Bprocessed
2024 Q32024-11-042.39B45.56%n/an/a682.00M28.56%1.50453.50M1.71B6.58Bprocessed
2024 Q22024-08-062.36B45.57%n/an/a624.00M26.43%1.37456.00M1.57B6.57Bprocessed
2024 Q12024-05-022.19B43.20%n/an/a599.00M27.35%1.31458.80M1.98B6.59Bprocessed
2023 Q42024-02-132.21B43.20%n/an/a525.00M23.72%1.14460.08M2.04B6.57Bprocessed
2023 Q32023-11-022.15B43.98%n/an/a596.00M27.71%1.29461.40M1.75B6.55Bprocessed
2023 Q22023-08-082.18B43.62%n/an/a671.00M30.78%1.45462.90M1.72B6.56Bprocessed
2023 Q12023-05-042.00B40.10%n/an/a552.00M27.60%1.19464.60M2.11B6.56Bprocessed
2022 Q42023-02-142.04B43.92%n/an/a461.00M22.60%0.99466.74M3.58B6.55Bprocessed
2022 Q32022-11-032.00B44.26%n/an/a529.00M26.42%1.13469.10M2.51B5.21Bprocessed
2022 Q22022-08-042.05B43.52%n/an/a529.00M25.78%1.12471.50M2.65B5.22Bprocessed
2022 Q12022-05-051.99B42.04%n/an/a595.00M29.96%1.26474.10M3.13B5.23Bprocessed
2021 Q42022-02-151.97B42.04%n/an/a414.00M21.05%0.87475.57M3.48B6.60Bprocessed
2021 Q32021-11-041.99B43.52%n/an/a552.00M27.74%1.16476.30M3.27B6.60Bprocessed
2021 Q22021-08-051.95B41.68%n/an/a512.00M26.28%1.07477.00M3.66B6.60Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.